These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32973715)

  • 21. Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.
    Yamada S; Kamada N; Amiya T; Nakamoto N; Nakaoka T; Kimura M; Saito Y; Ejima C; Kanai T; Saito H
    BMC Gastroenterol; 2017 Nov; 17(1):136. PubMed ID: 29187142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
    Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
    J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
    Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
    Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system.
    Chen M; Hou P; Zhou M; Ren Q; Wang X; Huang L; Hui S; Yi L; Mi M
    Clin Nutr; 2020 Apr; 39(4):1264-1275. PubMed ID: 31189495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
    Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
    Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic constant light exposure aggravates high fat diet-induced renal injury in rats.
    Xing L; Wu S; Shi Y; Yue F; Wei L; Russell R; Zhang D
    Front Endocrinol (Lausanne); 2022; 13():900392. PubMed ID: 35966094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.
    Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model.
    Li H; Wang Q; Chen P; Zhou C; Zhang X; Chen L
    Front Pharmacol; 2021; 12():788558. PubMed ID: 34938193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
    Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
    Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral Exposure to Polystyrene Microplastics of Mice on a Normal or High-Fat Diet and Intestinal and Metabolic Outcomes.
    Okamura T; Hamaguchi M; Hasegawa Y; Hashimoto Y; Majima S; Senmaru T; Ushigome E; Nakanishi N; Asano M; Yamazaki M; Sasano R; Nakanishi Y; Seno H; Takano H; Fukui M
    Environ Health Perspect; 2023 Feb; 131(2):27006. PubMed ID: 36821708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolyl Endopeptidase Gene Disruption Improves Gut Dysbiosis and Non-alcoholic Fatty Liver Disease in Mice Induced by a High-Fat Diet.
    Jiang D; Zhang J; Lin S; Wang Y; Chen Y; Fan J
    Front Cell Dev Biol; 2021; 9():628143. PubMed ID: 34095107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
    Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
    Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction.
    Cheng C; Tan J; Qian W; Zhang L; Hou X
    Life Sci; 2018 Sep; 209():157-166. PubMed ID: 30096384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats.
    Liang Y; Liang S; Zhang Y; Deng Y; He Y; Chen Y; Liu C; Lin C; Yang Q
    Probiotics Antimicrob Proteins; 2019 Mar; 11(1):175-185. PubMed ID: 29353414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of gut microbiota during silybin-mediated treatment of high-fat diet-induced non-alcoholic fatty liver disease in mice.
    Li X; Wang Y; Xing Y; Xing R; Liu Y; Xu Y
    Hepatol Res; 2020 Jan; 50(1):5-14. PubMed ID: 31661720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula.
    Yin X; Peng J; Zhao L; Yu Y; Zhang X; Liu P; Feng Q; Hu Y; Pang X
    Syst Appl Microbiol; 2013 May; 36(3):188-96. PubMed ID: 23453736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity.
    Zhang XY; Chen J; Yi K; Peng L; Xie J; Gou X; Peng T; Tang L
    Gut Microbes; 2020 Nov; 12(1):1-18. PubMed ID: 33222603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease.
    Petrov PD; García-Mediavilla MV; Guzmán C; Porras D; Nistal E; Martínez-Flórez S; Castell JV; González-Gallego J; Sánchez-Campos S; Jover R
    Mol Nutr Food Res; 2019 Oct; 63(20):e1900487. PubMed ID: 31322321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Hyperlipidemia and Gut Microbiota Community Regulation Effects of Selenium-Rich
    Yu M; Yue J; Hui N; Zhi Y; Hayat K; Yang X; Zhang D; Chu S; Zhou P
    Foods; 2021 Sep; 10(10):. PubMed ID: 34681302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway.
    Leng J; Huang F; Hai Y; Tian H; Liu W; Fang Y; Hu Y; Peng J
    Phytomedicine; 2020 Jan; 66():153135. PubMed ID: 31790895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.